Company: SXTPW
Filing Date: 2025-02-06
Form Type: 424B5
Source: 0001213900-25-010772
Chunk: 81

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-02-06
Form: 424B5
Chunk 81
---
. The phone number and facsimile number for Equity Stock Transfer are (212) 575-5757 and (347) 584-3644, respectively. Additional information about Equity Stock Transfer can be found on its website at www.equitystock.com.

Listing

Our common stock and Tradeable Warrants have been approved for listing on The Nasdaq Capital Market under the symbols “SXTP” and “SXTPW,” respectively.

<div align='center'>22

DESCRIPTION OF WARRANTS</div>

We may issue warrants for the purchase of shares of our common stock or preferred stock or of debt securities. We may issue warrants independently or together with other securities, and the warrants may be attached to or separate from any offered securities. Each series of warrants will be issued under a separate warrant agreement to be entered into between us and the investors or a warrant agent. The following summary of material provisions of the warrants and warrant agreements is subject to, and qualified in its entirety by reference to, all the provisions of the warrant agreement and warrant certificate applicable to a particular series of warrants. The terms of any warrants offered under a prospectus supplement may differ from the terms described below. We urge you to read the applicable prospectus supplement and any related free writing prospectus, as well as the complete warrant agreements and warrant certificates that contain the terms of the warrants.

The particular terms of any issue of warrants will be described in the prospectus supplement relating to the issue. Those terms may include:

| ● | the                                                                                                                                 
 number of shares of common stock or preferred stock purchasable upon the exercise of warrants to purchase such shares and the price 
 at which such number of shares may be purchased upon such exercise;                                                                 |

| ● | the                                                                                                                                    
 designation, stated value and terms (including, without limitation, liquidation, dividend, conversion and voting rights) of the series 
 of preferred stock purchasable upon exercise of warrants to purchase preferred stock;                                                  |

| ● | the                                                                                                                                
 principal amount of debt securities that may be purchased upon exercise of a debt warrant and the exercise price for the warrants, 
 which may be payable in cash, securities or other property;                                                                        |

| ● | the                                                                                                                               
 date, if any, on and after which the warrants and the related debt securities, preferred stock or common stock will be separately 
 transferable;                                                                                                                     |

| ● | the                                                 
 terms of any rights to redeem or call the warrants; |

| ● | the                                                                                                         
 date on which the right to exercise the warrants will